🇺🇸 Methotrexat in United States

409 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 61 reports (14.91%)
  2. Dyspnoea — 48 reports (11.74%)
  3. Pancytopenia — 46 reports (11.25%)
  4. Pyrexia — 43 reports (10.51%)
  5. Pneumonia — 40 reports (9.78%)
  6. Vomiting — 40 reports (9.78%)
  7. Arthralgia — 34 reports (8.31%)
  8. Sepsis — 34 reports (8.31%)
  9. Fall — 32 reports (7.82%)
  10. Asthenia — 31 reports (7.58%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Methotrexat approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Methotrexat in United States?

Biocad is the originator. The local marketing authorisation holder may differ — check the official source linked above.